Recombinant SARS-CoV-2 Spike Glycoprotein RBD (Kappa B.1.617/B.1.617.1/B.1.617.3 Variant) (Fc Tag), Unconjugated

Produktübersicht

• Artikelname: Recombinant SARS-CoV-2 Spike Glycoprotein RBD (Kappa B.1.617/B.1.617.1/B.1.617.3 Variant) (Fc Tag), Unconjugated
• Artikelnummer: ABC-A318168-100
• Hersteller Artikelnummer: A318168-100
• Alternativnummer: ABC-A318168-100
• Hersteller: Antibodies.com
• Kategorie: Proteine/Peptide
• Applikation: SDS-PAGE
• Konjugation: Unconjugated
• Alternative Synonym: sars-cov-2

Produktbeschreibung

Consists of amino acids Arg319-Phe541 of SARS-CoV-2 Spike Glycoprotein RBD (Kappa B.1.617/B.1.617.1/B.1.617.3 Variant) containing the following mutations: L452R and E484Q. The human Fc tag consists of amino acids Glu99-Ala330.

Produkteigenschaften

• Konzentration: Reconstitution dependent.
• Molekulargewicht: The protein has a predicted molecular mass of 51.2 kDa after removal of the signal peptide. The apparent molecular mass of RBD(L452Rand E484Q)-hFc is approximately 55-70 kDa due to glycosylation.
• Tag: C-terminal Human Fc Tag
• Puffer: Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%-8% Trehalose is added as a protectant before lyophilization.
• Expression System: HEK293 cells
• Reinheit: > 95% by SDS-PAGE and Coomassie blue staining.
• Formulierung: Lyophilized
• Sequenz: S protein RBD (L452Rand E484Q) (Arg319-Phe541) + hFc (Glu99-Ala330)
• Target-Kategorie: SARS-CoV-2 Spike Glycoprotein RBD